查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球口服固體合同製造市場：速釋機制獲得超過 50% 的份額
市場調查報告書
商品編碼
1077479

全球口服固體合同製造市場：速釋機制獲得超過 50% 的份額

Market Study on Oral Solid Dosage Contract Manufacturing: Immediate-release Mechanism to Account for Over 50% Market Share
出版日期: | 出版商: Persistence Market Research | 英文 278 Pages | 商品交期: 2-5個工作天內

價格

本報告探討了全球外包口服固體製劑市場、市場概況、主要趨勢、新型冠狀病毒感染（COVID-19）等市場影響因素分析、管道分析，總結了法律和監管環境、變化/市場規模預測、各類別/地區/主要國家細分、競爭分析、主要公司概況等。

目錄

第 1 章執行摘要

第2章市場概述

第3章主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第 4 章主要成功因素

  • 管道評估
  • 固體劑型粒子工程：案例研究/最佳實踐
  • 主要招聘策略：按入職者
  • 波特分析
  • PESTLE 分析
  • 最近的產品發布/批准
  • 主要規定
  • 價值鏈分析

第5章市場背景

  • 宏觀經濟因素
  • 預測變量：相關性/影響
  • 市場動態
    • 促進因素
    • 抑制器
    • 市場機會

第 6 章 COVID-19 分析

  • COVID-19 爆發的當前前景
  • 當前經濟前景/復甦情景
  • COVID-19：經濟影響
  • COVID-19：市場情景

第7章全球口服固體產品合同製造市場需求分析/預測

  • 過往市場分析
  • 當前和未來的市場預測

第8章全球口服固體產品合同製造市場分析/預測：按劑型

  • 簡介/主要發現
  • 過往市場分析
  • 當前和未來的市場分析/預測
    • 平板電腦
    • 膠囊
    • 膠囊/軟膠囊
    • 粉劑/顆粒劑
    • 錠劑
    • 軟糖
  • 市場吸引力

第9章口服固體產品合同製造市場分析/預測：按機制

  • 簡介/主要發現
  • 過往市場分析
  • 當前和未來的市場分析/預測
    • 立即發布
    • 延遲發布
    • 持續發布
  • 市場吸引力

第 10 章口服固體產品合同製造市場分析/預測：按應用

  • 簡介/主要發現
  • 過往市場分析
  • 當前和未來的市場分析/預測
    • 藥物開發
    • 填充和完成產品製造
    • 包裝/標籤
    • 其他
  • 市場吸引力

第 11 章口服固體配方合同製造市場分析/預測：按最終用戶

  • 簡介/主要發現
  • 過往市場分析
  • 當前和未來的市場分析/預測
    • 主要製藥和生物技術公司
    • 中小型製藥和生物技術公司
    • 新興和虛擬製藥公司
    • 膳食補充劑公司
  • 市場吸引力

第 12 章口服固體產品合同製造市場分析/預測：按地區劃分

  • 簡介/主要發現
  • 過往市場分析
  • 當前和未來的市場分析/預測
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東/非洲
  • 市場吸引力

第13章北美口服固體產品合同製造市場分析與預測

第14章拉丁美洲口服固體配方合同製造市場分析與預測

第15章歐洲口服固體配方合同製造市場分析與預測

第16章南亞口服固體配方製造市場分析與預測

第17章東亞口服固體產品合同製造市場分析與預測

第18章大洋洲口服固體配方合同製造市場分析/預測

第19章中東和非洲口服固體合同製造市場分析與預測

第20章市場結構分析

  • 市場分析：按公司層級
  • 主要公司的市場份額分析
  • 市場佔有率分析

第21章競爭分析

  • 競爭性儀表板
  • 競爭基準
  • 競技深潛
    • Recipharm AB
    • AbbVie
    • Patheon N.V.(Thermo Fisher Scientific)
    • Catalent Inc.
    • NextPharma
    • Capsugel(Lonza Group AG)
    • Aurobindo Pharma Limited
    • Siegfried AG
    • Piramal Pharma Solutions
    • Corden Pharma
    • Kremoint Pharma Pvt Ltd.
    • HERMES PHARMA GmbH
    • Medipaams India Private Limited
    • Alpex Pharma
    • Abaris Healthcare Pvt Ltd
    • Ardena Holdings N.V
    • Aphena Pharma Solutions
    • Actiza Pharmaceutical Private Limited
    • Sunwin Healthcare PVT. LTD
    • Saffron Medicare PVT. LTD
    • Kosher Pharmaceuticals
    • Dr Reddy's Lab
    • GlaxoSmithKline Plc
    • Boehringer Ingelheim BioXcellence
    • Aenova Holding

第 22 章假設/首字母縮略詞

第23章調查方法

Product Code: PMRREP25768

Oral Solid Dosage Contract Manufacturing Market: Scope of Report

The latest publication by Persistence Market Research on the global oral solid dosage contract manufacturing market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for oral solid dosage contract manufacturing products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the oral solid dosage contract manufacturing market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the oral solid dosage contract manufacturing market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the oral solid dosage contract manufacturing market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the oral solid dosage contract manufacturing market offers information divided into five important segments - dosage form, mechanism, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Dosage Form

Tablets

Conventional Release

Modified Release

Chewable Tablets

Effervescent Tablets

Capsules

Hard Gelatin Capsules

Soft Gelatin

Capsules/Softgels

Powders & Granules

Lozenges & Pastilles

Gummies

Mechanism

Immediate Release

Delayed Release

Controlled Release

Application

Drug Product Development

Fill & Finish Product Manufacturing

Packaging /Labelling

Others

End User

Big Pharma/Biotech Companies

Small- & Medium-size Pharma/Biotech Companies

Emerging/Virtual Pharma Companies

Nutraceutical Companies

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East & Africa

Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for oral solid dosage contract manufacturing over the coming years?

How will changing trends impact the market?

How has the COVID-19 crisis impacted market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will impact the market?

How can companies in the oral solid dosage contract manufacturing market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the oral solid dosage contract manufacturing market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the oral solid dosage contract manufacturing market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Pipeline Assessment
  • 4.2. Particle Engineering in Solid Dosage Formulation: Case Studies & Best Practices
  • 4.3. Key Strategies Adopted by market players
  • 4.4. Porters Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Recent Product Launches and Approvals
  • 4.7. Key Regulations
  • 4.8. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. COVID-19 Pandemic
    • 5.2.2. Rising Geriatric Population
    • 5.2.3. Rising Incidence of Chronic Diseases
    • 5.2.4. Patent Expiry and Demand for Generic Drugs
    • 5.2.5. Regulatory Policies
    • 5.2.6. Advancement in service development
    • 5.2.7. Service Availability in different regions
    • 5.2.8. Market Consolidation
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunities

6. COVID19 Crisis Analysis

  • 6.1. Current Perspectives on Coronavirus Outbreak
  • 6.2. Current Economic Outlook & Recovery Scenario
  • 6.3. Economic Impact of COVID-19
  • 6.4. COVID-19: 2021 Market Scenario

7. Global Oral Solid Dosage Contract Manufacturing Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Opportunity Analysis, 2022-2032

8. Global Oral Solid Dosage Contract Manufacturing Market Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) & Analysis By Dosage Form, 2017-2021
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Dosage Form, 2022-2032
    • 8.3.1. Tablets
      • 8.3.1.1. Conventional Release
      • 8.3.1.2. Modified Release
      • 8.3.1.3. Chewable Tablets
      • 8.3.1.4. Effervescent Tablets
    • 8.3.2. Capsules
      • 8.3.2.1. Hard Gelatin Capsules
      • 8.3.2.2. Soft Gelatin
    • 8.3.3. Capsules/Softgels
    • 8.3.4. Powders & Granules
    • 8.3.5. Lozenges & Pastilles
    • 8.3.6. Gummies
  • 8.4. Market Attractiveness Analysis By Dosage Form

9. Oral Solid Dosage Contract Manufacturing Market Analysis 2017-2021 and Forecast 2022-2032, by Mechanism

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis Mechanism, 2017-2021
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mechanism, 2022-2032
    • 9.3.1. Immediate Release
    • 9.3.2. Delayed Release
    • 9.3.3. Controlled Release
  • 9.4. Market Attractiveness Analysis By Mechanism

10. Oral Solid Dosage Contract Manufacturing Market Analysis 2017-2021 and Forecast 2022-2032, by Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Application, 2017-2021
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032
    • 10.3.1. Drug Product Development
    • 10.3.2. Fil & Finish Product Manufacturing
    • 10.3.3. Packaging /Labelling
    • 10.3.4. Others
  • 10.4. Market Attractiveness Analysis By Application

11. Oral Solid Dosage Contract Manufacturing Market Analysis 2017-2021 and Forecast 2022-2032, by End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2021
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032
    • 11.3.1. Big Pharma/Biotech Companies
    • 11.3.2. Small & Medium Size Pharma/Biotech Companies
    • 11.3.3. Emerging/virtual Pharma Companies
    • 11.3.4. Nutraceutical Companies
  • 11.4. Market Attractiveness Analysis By End User

12. Oral Solid Dosage Contract Manufacturing Market Analysis 2017-2021 and Forecast 2022-2032, by Region

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa
  • 12.4. Market Attractiveness Analysis By Region

13. North America Oral Solid Dosage Contract Manufacturing Market Analysis 2017-2021 and Forecast 2022-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Dosage Form
    • 13.3.3. By Mechanism
    • 13.3.4. By Application
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Drivers and Restraints - Impact Analysis

14. Latin America Oral Solid Dosage Contract Manufacturing Market Analysis 2017-2021 and Forecast 2022-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032
    • 14.3.1. By Country
      • 14.3.1.1. Brazil
      • 14.3.1.2. Mexico
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Dosage Form
    • 14.3.3. By Mechanism
    • 14.3.4. By Application
    • 14.3.5. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Drivers and Restraints - Impact Analysis

15. Europe Oral Solid Dosage Contract Manufacturing Market Analysis 2017-2021 and Forecast 2022-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. Italy
      • 15.3.1.3. France
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. Netherlands
      • 15.3.1.7. Russia
      • 15.3.1.8. Rest of Europe
    • 15.3.2. By Dosage Form
    • 15.3.3. By Mechanism
    • 15.3.4. By Application
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Drivers and Restraints - Impact Analysis

16. South Asia Oral Solid Dosage Contract Manufacturing Market Analysis 2017-2021 and Forecast 2022-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Thailand
      • 16.3.1.3. Indonesia
      • 16.3.1.4. Malaysia
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Dosage Form
    • 16.3.3. By Mechanism
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Drivers and Restraints - Impact Analysis

17. East Asia Oral Solid Dosage Contract Manufacturing Market Analysis 2017-2021 and Forecast 2022-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Dosage Form
    • 17.3.3. By Mechanism
    • 17.3.4. By Application
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Drivers and Restraints - Impact Analysis

18. Oceania Oral Solid Dosage Contract Manufacturing Market Analysis 2017-2021 and Forecast 2022-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Dosage Form
    • 18.3.3. By Mechanism
    • 18.3.4. By Application
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Oral Solid Dosage Contract Manufacturing Market Analysis 2017-2021 and Forecast 2022-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkey
      • 19.3.1.3. South Africa
      • 19.3.1.4. Rest of Middle East and Africa
    • 19.3.2. By Dosage Form
    • 19.3.3. By Mechanism
    • 19.3.4. By Application
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
  • 19.5. Drivers and Restraints - Impact Analysis

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis
    • 20.3.1. Regional Footprint by Players
    • 20.3.2. Product Foot print by Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Recipharm AB
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Strategy Overview
    • 21.3.2. AbbVie
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Strategy Overview
    • 21.3.3. Patheon N.V. (Thermo Fisher Scientific)
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Strategy Overview
    • 21.3.4. Catalent Inc.
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Strategy Overview
    • 21.3.5. NextPharma
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Strategy Overview
    • 21.3.6. Capsugel (Lonza Group AG)
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Strategy Overview
    • 21.3.7. Aurobindo Pharma Limited
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Strategy Overview
    • 21.3.8. Siegfried AG
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Strategy Overview
    • 21.3.9. Piramal Pharma Solutions
      • 21.3.9.1. Overview
      • 21.3.9.2. Product Portfolio
      • 21.3.9.3. Strategy Overview
    • 21.3.10. Corden Pharma
      • 21.3.10.1. Overview
      • 21.3.10.2. Product Portfolio
      • 21.3.10.3. Strategy Overview
    • 21.3.11. Kremoint Pharma Pvt Ltd.
      • 21.3.11.1. Overview
      • 21.3.11.2. Product Portfolio
      • 21.3.11.3. Strategy Overview
    • 21.3.12. HERMES PHARMA GmbH
      • 21.3.12.1. Overview
      • 21.3.12.2. Product Portfolio
      • 21.3.12.3. Strategy Overview
    • 21.3.13. Medipaams India Private Limited
      • 21.3.13.1. Overview
      • 21.3.13.2. Product Portfolio
      • 21.3.13.3. Strategy Overview
    • 21.3.14. Alpex Pharma
      • 21.3.14.1. Overview
      • 21.3.14.2. Product Portfolio
      • 21.3.14.3. Strategy Overview
    • 21.3.15. Abaris Healthcare Pvt Ltd
      • 21.3.15.1. Overview
      • 21.3.15.2. Product Portfolio
      • 21.3.15.3. Strategy Overview
    • 21.3.16. Ardena Holdings N.V
      • 21.3.16.1. Overview
      • 21.3.16.2. Product Portfolio
      • 21.3.16.3. Strategy Overview
    • 21.3.17. Aphena Pharma Solutions
      • 21.3.17.1. Overview
      • 21.3.17.2. Product Portfolio
      • 21.3.17.3. Strategy Overview
    • 21.3.18. Actiza Pharmaceutical Private Limited
      • 21.3.18.1. Overview
      • 21.3.18.2. Product Portfolio
      • 21.3.18.3. Strategy Overview
    • 21.3.19. Sunwin Healthcare PVT. LTD
      • 21.3.19.1. Overview
      • 21.3.19.2. Product Portfolio
      • 21.3.19.3. Strategy Overview
    • 21.3.20. Saffron Medicare PVT. LTD
      • 21.3.20.1. Overview
      • 21.3.20.2. Product Portfolio
      • 21.3.20.3. Strategy Overview
    • 21.3.21. Kosher Pharmaceuticals
      • 21.3.21.1. Overview
      • 21.3.21.2. Product Portfolio
      • 21.3.21.3. Strategy Overview
    • 21.3.22. Dr Reddy's Lab
      • 21.3.22.1. Overview
      • 21.3.22.2. Product Portfolio
      • 21.3.22.3. Strategy Overview
    • 21.3.23. GlaxoSmithKline Plc
      • 21.3.23.1. Overview
      • 21.3.23.2. Product Portfolio
      • 21.3.23.3. Strategy Overview
    • 21.3.24. Boehringer Ingelheim BioXcellence
      • 21.3.24.1. Overview
      • 21.3.24.2. Product Portfolio
      • 21.3.24.3. Strategy Overview
    • 21.3.25. Aenova Holding
      • 21.3.25.1. Overview
      • 21.3.25.2. Product Portfolio
      • 21.3.25.3. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

List of Tables

  • Table 01: Global Oral Solid Dosage Contract Manufacturing Market Size Analysis (US$ Mn) Analysis 2017-2021 and Forecast 2022 - 2032, By Dosage Form
  • Table 02: Global Oral Solid Dosage Contract Manufacturing Market Size Analysis (US$ Mn) Analysis 2017-2021 and Forecast 2022 - 2032, By Mechanism
  • Table 03: Global Oral Solid Dosage Contract Manufacturing Market Size Analysis (US$ Mn) Analysis 2017-2021 and Forecast 2022 - 2032, By Application
  • Table 04: Global Oral Solid Dosage Contract Manufacturing Market Size Analysis (US$ Mn) Analysis 2017-2021 and Forecast 2022 - 2032, By End User
  • Table 05: Global Oral Solid Dosage Contract Manufacturing Market Size Analysis (US$ Mn) Analysis 2017-2021 and Forecast 2022 - 2032, By Region
  • Table 06: North America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
  • Table 07: North America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
  • Table 08: North America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
  • Table 09: North America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
  • Table 10: North America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
  • Table 11: Latin America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
  • Table 12: Latin America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
  • Table 13: Latin America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
  • Table 14: Latin America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
  • Table 15: Latin America Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
  • Table 16: Europe Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
  • Table 17: Europe Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
  • Table 18: Europe Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
  • Table 19: Europe Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
  • Table 20: Europe Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
  • Table 21: South Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
  • Table 22: South Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
  • Table 23: South Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
  • Table 24: South Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
  • Table 25: South Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
  • Table 26: East Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
  • Table 27: East Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
  • Table 28: East Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
  • Table 29: East Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
  • Table 30: East Asia Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
  • Table 31: Oceania Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
  • Table 32: Oceania Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
  • Table 33: Oceania Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
  • Table 34: Oceania Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
  • Table 35: Oceania Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
  • Table 36: Middle East & Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
  • Table 37: Middle East And Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Dosage Form
  • Table 38: Middle East and Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Mechanism
  • Table 39: Middle East and Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
  • Table 40: Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

List of Figures

  • Figure 01: Global Oral Solid Dosage Contract Manufacturing Market Historical Market Value (US$ Mn) Analysis, 2017-2021
  • Figure 02: Global Oral Solid Dosage Contract Manufacturing Market Value (US$ Mn), 2022 - 2032 & Y-o-Y Growth Trend Analysis
  • Figure 03: Global Oral Solid Dosage Contract Manufacturing Market Absolute $ Opportunity, 2022-2032
  • Figure 04: Global Oral Solid Dosage Contract Manufacturing Market Share Analysis (%) By Dosage Form, 2022 & 2032
  • Figure 05: Global Oral Solid Dosage Contract Manufacturing Market Y-o-Y Growth (%) By Dosage Form, 2022 - 2032
  • Figure 06: Global Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis By Dosage Form, 2022 - 2032
  • Figure 07: Global Oral Solid Dosage Contract Manufacturing Market Share Analysis (%) By Mechanism, 2022 & 2032
  • Figure 08: Global Oral Solid Dosage Contract Manufacturing Market Y-o-Y Growth (%) By Mechanism, 2022 - 2032
  • Figure 09: Global Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis By Mechanism, 2022 - 2032
  • Figure 10: Global Oral Solid Dosage Contract Manufacturing Market Share Analysis (%) By Application, 2022 & 2032
  • Figure 11: Global Oral Solid Dosage Contract Manufacturing Market Y-o-Y Growth (%) By Application, 2022 - 2032
  • Figure 12: Global Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis By Application, 2022 - 2032
  • Figure 13: Global Oral Solid Dosage Contract Manufacturing Market Share Analysis (%) By End User, 2022 & 2032
  • Figure 14: Global Oral Solid Dosage Contract Manufacturing Market Y-o-Y Growth (%) By End User, 2022 - 2032
  • Figure 15: Global Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis By End User, 2022 - 2032
  • Figure 16: Global Oral Solid Dosage Contract Manufacturing Market Share Analysis (%) By Region, 2022 & 2032
  • Figure 17: Global Oral Solid Dosage Contract Manufacturing Market Y-o-Y Growth (%) By Region, 2022 - 2032
  • Figure 18: Global Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis By Region, 2022 - 2032
  • Figure 19: North America Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Dosage Form (2021)
  • Figure 20: North America Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Mechanism (2021)
  • Figure 21: North America Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Application (2021)
  • Figure 22: North America Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By End User (2021)
  • Figure 23: North America Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Country (2021)
  • Figure 24: North America Oral Solid Dosage Contract Manufacturing Historical Market Value (US$ Mn) Analysis, 2017-2021
  • Figure 25: North America Oral Solid Dosage Contract Manufacturing Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
  • Figure 26: North America Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Country
  • Figure 27: North America Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Dosage Form
  • Figure 28: North America Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Mechanism
  • Figure 29: North America Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Application
  • Figure 30: North America Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By End User
  • Figure 31: Latin America Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Dosage Form (2021)
  • Figure 32: Latin America Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Mechanism (2021)
  • Figure 33: Latin America Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Application (2021)
  • Figure 34: Latin America Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By End User (2021)
  • Figure 35: Latin America Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Country (2021)
  • Figure 36: Latin America Oral Solid Dosage Contract Manufacturing Historical Market Value (US$ Mn) Analysis, 2017-2021
  • Figure 37: Latin America Oral Solid Dosage Contract Manufacturing Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
  • Figure 38: Latin America Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Country
  • Figure 39: Latin America Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Dosage Form
  • Figure 40: Latin America Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Mechanism
  • Figure 41: Latin America Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Application
  • Figure 42: Latin America Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By End User
  • Figure 43: Europe Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Dosage Form (2021)
  • Figure 44: Europe Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Mechanism (2021)
  • Figure 45: Europe Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Application (2021)
  • Figure 46: Europe Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By End User (2021)
  • Figure 47: Europe Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Country (2021)
  • Figure 48: Europe Oral Solid Dosage Contract Manufacturing Historical Market Value (US$ Mn) Analysis, 2017-2021
  • Figure 49: Europe Oral Solid Dosage Contract Manufacturing Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
  • Figure 50: Europe Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Country
  • Figure 51: Europe Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Dosage Form
  • Figure 52: Europe Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Mechanism
  • Figure 53: Europe Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Application
  • Figure 54: Europe Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By End User
  • Figure 55: South Asia Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Dosage Form (2021)
  • Figure 56: South Asia Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Mechanism (2021)
  • Figure 57: South Asia Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Application (2021)
  • Figure 58: South Asia Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By End User (2021)
  • Figure 59: South Asia Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Country (2021)
  • Figure 60: South Asia Oral Solid Dosage Contract Manufacturing Historical Market Value (US$ Mn) Analysis, 2017-2021
  • Figure 61: South Asia Oral Solid Dosage Contract Manufacturing Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
  • Figure 62: South Asia Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Country
  • Figure 63: South Asia Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Dosage Form
  • Figure 64: South Asia Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Mechanism
  • Figure 65: South Asia Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Application
  • Figure 66: South Asia Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By End User
  • Figure 67: East Asia Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Dosage Form (2021)
  • Figure 68: East Asia Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Mechanism (2021)
  • Figure 69: East Asia Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Application (2021)
  • Figure 70: East Asia Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By End User (2021)
  • Figure 71: East Asia Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Country (2021)
  • Figure 72: East Asia Oral Solid Dosage Contract Manufacturing Historical Market Value (US$ Mn) Analysis, 2017-2021
  • Figure 73: East Asia Oral Solid Dosage Contract Manufacturing Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
  • Figure 74: East Asia Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Country
  • Figure 75: East Asia Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Dosage Form
  • Figure 76: East Asia Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Mechanism
  • Figure 77: East Asia Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Application
  • Figure 78: East Asia Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By End User
  • Figure 79: Oceania Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Dosage Form (2021)
  • Figure 80: Oceania Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Mechanism (2021)
  • Figure 81: Oceania Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Application (2021)
  • Figure 82: Oceania Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By End User (2021)
  • Figure 83: Oceania Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Country (2021)
  • Figure 84: Oceania Oral Solid Dosage Contract Manufacturing Historical Market Value (US$ Mn) Analysis, 2017-2021
  • Figure 85: Oceania Oral Solid Dosage Contract Manufacturing Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
  • Figure 86: Oceania Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Country
  • Figure 87: Oceania Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Dosage Form
  • Figure 88: Oceania Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Mechanism
  • Figure 89: Oceania Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Application
  • Figure 90: Oceania Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By End User
  • Figure 91: Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Dosage Form (2021)
  • Figure 92: Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Mechanism (2021)
  • Figure 93: Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Application (2021)
  • Figure 94: Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By End User (2021)
  • Figure 95: Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Analysis Market Share, By Country (2021)
  • Figure 96: Middle East & Africa (MEA) Oral Solid Dosage Contract Manufacturing Historical Market Value (US$ Mn) Analysis, 2017-2021
  • Figure 97: Middle East & Africa (MEA) Oral Solid Dosage Contract Manufacturing Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
  • Figure 98: Middle East & Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Country
  • Figure 99: Middle East & Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Dosage Form
  • Figure 100: Middle East & Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Mechanism
  • Figure 101: Middle East & Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By Application
  • Figure 102: Middle East & Africa (MEA) Oral Solid Dosage Contract Manufacturing Market Attractiveness Analysis, By End User